HGS Spin-off Licenses Technology from Parent Company
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 73 (Table of Contents)
Published: 6 Jul-2006
DOI: 10.3833/pdr.v2006.i73.490 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Human Genome Sciences (HGS) granted CoGenesys (a spin-off company of HGS) the exclusive rights to develop and commercialize biological products against human gene targets identified by HGS...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018